Toll Free: 1-888-928-9744

Global Recombinant Protein Drug Market Professional Survey Report 2016

Published: Jun 8, 2016 | Pages: 109 | Publisher: QYResearch | Industry: Chemicals & Materials | Report Format: Electronic (PDF)

This report mainly covers the following

Product types including Recombinant Insulin Recombinant Human Interferon (rhIFN) Recombinant Human Erythropoietin (rhEPO) Recombinant Human Granulocyte Colony-stimulating Factor (rhG-CSF) Recombinant Human Growth Hormone (rhGH) Recombinant Human Follicle-stimulating Hormone (rhFSH) Others
The segment applications including Hospital use Clinic use Household
Segment regions including (the separated region report can also be offered) North America Europe Japan China Southeast Asia India
The players list (Partly, Players you are interested in can also be added) Novo Nordisk Amgen Sanofi Eli Lilly Merck Serono Ortho Biotech Roche Kyowa Hakko Kirin Pharmingen Abcam GenSci SL PHARM Shenzhen Neptunus Interlong Bio-Technique Co., Ltd. Anhui Anke Biotechnology NCPC Heng Rui Changchun High & New Technology Industry (Group) Inc Livzon Pharmaceutical Group Inc With 18 top producers. Data including (both global and regions): Market Size (both volume - Unit and value - million USD), Market Share, Production data, Consumption data, Trade data, Price - USD/Unit, Cost, Gross margin etc. More detailed information, please refer to the attachment file and table of contents. If you have other requirements, please contact us, we can also offer!
 Table of Contents
1 Industry Overview of Recombinant Protein Drug 1.1 Definition and Specifications of Recombinant Protein Drug 1.1.1 Definition of Recombinant Protein Drug 1.1.2 Specifications of Recombinant Protein Drug 1.2 Classification of Recombinant Protein Drug 1.2.1 Recombinant Insulin 1.2.2 Recombinant Human Interferon (rhIFN) 1.2.3 Recombinant Human Erythropoietin (rhEPO) 1.2.4 Recombinant Human Granulocyte Colony-stimulating Factor (rhG-CSF) 1.2.5 Recombinant Human Growth Hormone (rhGH) 1.2.6 Recombinant Human Follicle-stimulating Hormone (rhFSH) 1.2.7 Others 1.3 Applications of Recombinant Protein Drug 1.3.1 Hospital use 1.3.2 Clinic use 1.3.3 Household 1.4 Industry Chain Structure of Recombinant Protein Drug 1.5 Industry Overview and Major Regions Status of Recombinant Protein Drug 1.5.1 Industry Overview of Recombinant Protein Drug 1.5.2 Global Major Regions Status of Recombinant Protein Drug 1.6 Industry Policy Analysis of Recombinant Protein Drug 1.7 Industry News Analysis of Recombinant Protein Drug 2 Manufacturing Cost Structure Analysis of Recombinant Protein Drug 2.1 Raw Material Suppliers and Price Analysis of Recombinant Protein Drug 2.2 Equipment Suppliers and Price Analysis of Recombinant Protein Drug 2.3 Labor Cost Analysis of Recombinant Protein Drug 2.4 Other Costs Analysis of Recombinant Protein Drug 2.5 Manufacturing Cost Structure Analysis of Recombinant Protein Drug 2.6 Manufacturing Process Analysis of Recombinant Protein Drug 3 Technical Data and Manufacturing Plants Analysis of Recombinant Protein Drug 3.1 Capacity and Commercial Production Date of Global Recombinant Protein Drug Major Manufacturers in 2015 3.2 Manufacturing Plants Distribution of Global Recombinant Protein Drug Major Manufacturers in 2015 3.3 R&D Status and Technology Source of Global Recombinant Protein Drug Major Manufacturers in 2015 3.4 Raw Materials Sources Analysis of Global Recombinant Protein Drug Major Manufacturers in 2015 4 Global Recombinant Protein Drug Overall Market Overview 4.1 2011-2016E Overall Market Analysis 4.2.1 2011-2015 Global Recombinant Protein Drug Capacity and Growth Rate Analysis 4.2.2 2015 Recombinant Protein Drug Capacity Analysis (Company Segment) 4.3 Sales Analysis 4.3.1 2011-2015 Global Recombinant Protein Drug Sales and Growth Rate Analysis 4.3.2 2015 Recombinant Protein Drug Sales Analysis (Company Segment) 4.4 Sales Price Analysis 4.4.1 2011-2015 Global Recombinant Protein Drug Sales Price 4.4.2 2015 Recombinant Protein Drug Sales Price Analysis (Company Segment) 4.5 Gross Margin Analysis 4.5.1 2011-2015 Global Recombinant Protein Drug Gross Margin 4.5.2 2015 Recombinant Protein Drug Gross Margin Analysis (Company Segment) 5 Recombinant Protein Drug Regional Market Analysis 5.1 North America Recombinant Protein Drug Market Analysis 5.1.1 North America Recombinant Protein Drug Market Overview 5.1.2 North America 2011-2016E Recombinant Protein Drug Local Supply, Import, Export, Local Consumption Analysis 5.1.3 North America 2011-2016E Recombinant Protein Drug Sales Price Analysis 5.1.4 North America 2015 Recombinant Protein Drug Market Share Analysis 5.2 Europe Recombinant Protein Drug Market Analysis 5.2.1 Europe Recombinant Protein Drug Market Overview 5.2.2 Europe 2011-2016E Recombinant Protein Drug Local Supply, Import, Export, Local Consumption Analysis 5.2.3 Europe 2011-2016E Recombinant Protein Drug Sales Price Analysis 5.2.4 Europe 2015 Recombinant Protein Drug Market Share Analysis 5.3 Japan Recombinant Protein Drug Market Analysis 5.3.1 Japan Recombinant Protein Drug Market Overview 5.3.2 Japan 2011-2016E Recombinant Protein Drug Local Supply, Import, Export, Local Consumption Analysis 5.3.3 Japan 2011-2016E Recombinant Protein Drug Sales Price Analysis 5.3.4 Japan 2015 Recombinant Protein Drug Market Share Analysis 5.4 China Recombinant Protein Drug Market Analysis 5.4.1 China Recombinant Protein Drug Market Overview 5.4.2 China 2011-2016E Recombinant Protein Drug Local Supply, Import, Export, Local Consumption Analysis 5.4.3 China 2011-2016E Recombinant Protein Drug Sales Price Analysis 5.4.4 China 2015 Recombinant Protein Drug Market Share Analysis 5.5 Southeast Asia Recombinant Protein Drug Market Analysis 5.5.1 Southeast Asia Recombinant Protein Drug Market Overview 5.5.2 Southeast Asia 2011-2016E Recombinant Protein Drug Local Supply, Import, Export, Local Consumption Analysis 5.5.3 Southeast Asia 2011-2016E Recombinant Protein Drug Sales Price Analysis 5.5.4 Southeast Asia 2015 Recombinant Protein Drug Market Share Analysis 5.6 India Recombinant Protein Drug Market Analysis 5.6.1 India Recombinant Protein Drug Market Overview 5.6.2 India 2011-2016E Recombinant Protein Drug Local Supply, Import, Export, Local Consumption Analysis 5.6.3 India 2011-2016E Recombinant Protein Drug Sales Price Analysis 5.6.4 India 2015 Recombinant Protein Drug Market Share Analysis 6 Global 2011-2016E Recombinant Protein Drug Segment Market Analysis (by Type) 6.1 Global 2011-2016E Recombinant Protein Drug Sales by Type 6.2 Different Types Recombinant Protein Drug Product Interview Price Analysis 6.3 Different Types Recombinant Protein Drug Product Driving Factors Analysis 6.3.1 Recombinant Insulin Recombinant Protein Drug Growth Driving Factor Analysis 6.3.2 Recombinant Human Interferon (rhIFN) Recombinant Protein Drug Growth Driving Factor Analysis 6.3.3 Recombinant Human Erythropoietin (rhEPO) Recombinant Protein Drug Growth Driving Factor Analysis 6.3.4 Recombinant Human Granulocyte Colony-stimulating Factor (rhG-CSF) Recombinant Protein Drug Growth Driving Factor Analysis 6.3.5 Recombinant Human Growth Hormone (rhGH) Recombinant Protein Drug Growth Driving Factor Analysis 6.3.6 Recombinant Human Follicle-stimulating Hormone (rhFSH) Recombinant Protein Drug Growth Driving Factor Analysis 6.3.7 Others Recombinant Protein Drug Growth Driving Factor Analysis 7 Global 2011-2016E Recombinant Protein Drug Segment Market Analysis (by Application) 7.1 Global 2011-2016E Consumption by Application 7.2 Different Application Product Interview Price Analysis 7.3 Different Application Product Driving Factors Analysis 7.3.1 Hospital use Recombinant Protein Drug Growth Driving Factor Analysis 7.3.2 Clinic use Recombinant Protein Drug Growth Driving Factor Analysis 7.3.3 Household Recombinant Protein Drug Growth Driving Factor Analysis 8 Major Manufacturers Analysis of Recombinant Protein Drug 8.1 Novo Nordisk 8.1.1 Company Profile 8.1.2 Product Picture and Specifications 8.1.3 Novo Nordisk 2015 Recombinant Protein Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.1.4 Novo Nordisk 2015 Recombinant Protein Drug Business Region Distribution Analysis 8.2 Amgen 8.2.1 Company Profile 8.2.2 Product Picture and Specifications 8.2.3 Amgen 2015 Recombinant Protein Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.2.4 Amgen 2015 Recombinant Protein Drug Business Region Distribution Analysis 8.3 Sanofi 8.3.1 Company Profile 8.3.2 Product Picture and Specifications 8.3.3 Sanofi 2015 Recombinant Protein Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.3.4 Sanofi 2015 Recombinant Protein Drug Business Region Distribution Analysis 8.4 Eli Lilly 8.4.1 Company Profile 8.4.2 Product Picture and Specifications 8.4.3 Eli Lilly 2015 Recombinant Protein Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.4.4 Eli Lilly 2015 Recombinant Protein Drug Business Region Distribution Analysis 8.5 Merck Serono 8.5.1 Company Profile 8.5.2 Product Picture and Specifications 8.5.3 Merck Serono 2015 Recombinant Protein Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.5.4 Merck Serono 2015 Recombinant Protein Drug Business Region Distribution Analysis 8.6 Ortho Biotech 8.6.1 Company Profile 8.6.2 Product Picture and Specifications 8.6.3 Ortho Biotech 2015 Recombinant Protein Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.6.4 Ortho Biotech 2015 Recombinant Protein Drug Business Region Distribution Analysis 8.7 Roche 8.7.1 Company Profile 8.7.2 Product Picture and Specifications 8.7.3 Roche 2015 Recombinant Protein Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.7.4 Roche 2015 Recombinant Protein Drug Business Region Distribution Analysis 8.8 Kyowa Hakko Kirin 8.8.1 Company Profile 8.8.2 Product Picture and Specifications 8.8.3 Kyowa Hakko Kirin 2015 Recombinant Protein Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.8.4 Kyowa Hakko Kirin 2015 Recombinant Protein Drug Business Region Distribution Analysis 8.9 Pharmingen 8.9.1 Company Profile 8.9.2 Product Picture and Specifications 8.9.3 Pharmingen 2015 Recombinant Protein Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.9.4 Pharmingen 2015 Recombinant Protein Drug Business Region Distribution Analysis 8.10 Abcam 8.10.1 Company Profile 8.10.2 Product Picture and Specifications 8.10.3 Abcam 2015 Recombinant Protein Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.10.4 Abcam 2015 Recombinant Protein Drug Business Region Distribution Analysis 8.11 GenSci 8.11.1 Company Profile 8.11.2 Product Picture and Specifications 8.11.3 GenSci 2015 Recombinant Protein Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.11.4 GenSci 2015 Recombinant Protein Drug Business Region Distribution Analysis 8.12 SL PHARM 8.12.1 Company Profile 8.12.2 Product Picture and Specifications 8.12.3 SL PHARM 2015 Recombinant Protein Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.12.4 SL PHARM 2015 Recombinant Protein Drug Business Region Distribution Analysis 8.13 Shenzhen Neptunus Interlong Bio-Technique Co., Ltd. 8.13.1 Company Profile 8.13.2 Product Picture and Specifications 8.13.3 Shenzhen Neptunus Interlong Bio-Technique Co., Ltd. 2015 Recombinant Protein Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.13.4 Shenzhen Neptunus Interlong Bio-Technique Co., Ltd. 2015 Recombinant Protein Drug Business Region Distribution Analysis 8.14 Anhui Anke Biotechnology 8.14.1 Company Profile 8.14.2 Product Picture and Specifications 8.14.3 Anhui Anke Biotechnology 2015 Recombinant Protein Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.14.4 Anhui Anke Biotechnology 2015 Recombinant Protein Drug Business Region Distribution Analysis 8.15 NCPC 8.15.1 Company Profile 8.15.2 Product Picture and Specifications 8.15.3 NCPC 2015 Recombinant Protein Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.15.4 NCPC 2015 Recombinant Protein Drug Business Region Distribution Analysis 8.16 Heng Rui 8.16.1 Company Profile 8.16.2 Product Picture and Specifications 8.16.3 Heng Rui 2015 Recombinant Protein Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.16.4 Heng Rui 2015 Recombinant Protein Drug Business Region Distribution Analysis 8.17 Changchun High & New Technology Industry (Group) Inc 8.17.1 Company Profile 8.17.2 Product Picture and Specifications 8.17.3 Changchun High & New Technology Industry (Group) Inc 2015 Recombinant Protein Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.17.4 Changchun High & New Technology Industry (Group) Inc 2015 Recombinant Protein Drug Business Region Distribution Analysis 8.18 Livzon Pharmaceutical Group Inc 8.18.1 Company Profile 8.18.2 Product Picture and Specifications 8.18.3 Livzon Pharmaceutical Group Inc 2015 Recombinant Protein Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.18.4 Livzon Pharmaceutical Group Inc 2015 Recombinant Protein Drug Business Region Distribution Analysis 9 Development Trend of Analysis of Market 9.1 Global Market Trend Analysis 9.1.1 Global 2016-2021 Market Size (Volume and Value) Forecast 9.1.2 Global 2016-2021 Sales Price Forecast 9.1.3 Global 2016-2021 Gross Margin Forecast 9.2 Regional Market Trend 9.2.1 North America 2016-2021 Recombinant Protein Drug Consumption Forecast 9.2.2 Europe 2016-2021 Recombinant Protein Drug Consumption Forecast 9.2.3 Japan 2016-2021 Recombinant Protein Drug Consumption Forecast 9.2.4 China 2016-2021 Recombinant Protein Drug Consumption Forecast 9.2.5 Southeast Asia 2016-2021 Recombinant Protein Drug Consumption Forecast 9.2.6 India 2016-2021 Recombinant Protein Drug Consumption Forecast 9.3 Market Trend (Product type) 9.4 Market Trend (Application) 10 Recombinant Protein Drug Marketing Model Analysis 10.1 Recombinant Protein Drug Regional Marketing Model Analysis 10.2 Recombinant Protein Drug International Trade Model Analysis 10.3 Traders or Distributors with Contact Information of Recombinant Protein Drug by Regions 10.4 Recombinant Protein Drug Supply Chain Analysis 11 Consumers Analysis of Recombinant Protein Drug 11.1 Consumer 1 Analysis 11.2 Consumer 2 Analysis 11.3 Consumer 3 Analysis 11.4 Consumer 4 Analysis … 12 New Project Investment Feasibility Analysis of Recombinant Protein Drug 12.1 New Project SWOT Analysis of Recombinant Protein Drug 12.2 New Project Investment Feasibility Analysis of Recombinant Protein Drug 13 Conclusion of the Global Recombinant Protein Drug Market Professional Survey Report 2016

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global automotive collision repair market is expected to be valued at USD 196.97 billion by 2020, as per a new research report by Radiant Insights, Inc. The industry is expected to witness significant growth owing to increasing number of on-road vehi

Read More...

Global LCP (Liquid Crystal Polymer) industry is forecasted to reach USD 1.23 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing trend towards developing militarized components and connectors are likely to drive the demand

Read More...

Global compressed air treatment equipment market is projected to reach USD 8.59 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing implementation of this equipment in various industry sectors such as healthcare & pharmace

Read More...

Global Automated Test Equipment (ATE) market is expected to be valued at USD 4.48 billion by 2020, as per a new research report by Radiant Insights, Inc. Increasing design complexity coupled with need for effective testing is expected to drive the gl

Read More...

Global thermoplastic polyurethane (TPU) films market size is likely to be valued at USD 724.6 million by 2020; as per a new research report by Radiant Insights, Inc. Increase in lightweight plastics demand in order to achieve vehicle fuel efficiency

Read More...
Choose License Type
Single User - US $3500
Multi User - US $7000
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify